CYTOSORBENTS CORP (CTSO) Institutional Ownership

CTSO is currently held by 1 institutional investors tracked by InsiderSet, with a combined reported market value of approximately $57,038 based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026.

The largest disclosed holder is Renaissance Technologies LLC, which reported ownership valued at approximately $57,038 in its March 31, 2026 13F filing. Based on current market prices and the latest disclosed share count, Renaissance Technologies LLC's CTSO position is now estimated to be worth approximately $48,043.44, representing an estimated loss of -15.77% since the filing period.

Major shareholders tracked on this page include Renaissance Technologies LLC, and other prominent asset managers. Collectively, these investors account for approximately 100% of the total disclosed value among the investors covered in this analysis.

This page tracks smart money ownership trends, hedge fund exposure, portfolio concentration, historical 13F filings, and estimated holding performance to help investors analyze smart money sentiment toward CYTOSORBENTS CORP (CTSO).

Institutional Ownership Trend

Portfolio quarterInstitutional holdersTotal reported valueTotal shares
Q1 20261$57,038100,720
Q4 20251$63,997100,120
Q3 20251$125,921134,805
Q2 20251$149,298116,639
Q1 20251$225,254225,254
Q4 20241$80,09888,020
Q3 20241$119,43079,620
Q2 20241$53,30175,820
Q1 20241$7679,620
Q4 20231$195175,320
Q3 20231$224119,100
Q2 20231$427118,900